LOW DOSE VALGANCICLOVIR AS A PRE-EMPTIVE THERAPY IS EFFECTIVE FOR CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE

被引：0
|
作者：
Jeon, Jin Seok [1 ]
Lee, Haekyung [1 ]
Kim, Hyoungnae [1 ]
Kwon, Soon Hyo [1 ]
Noh, Hyunjin [1 ]
机构：
[1] Soonchunhyang Univ Hosp, Dept Internal Med, Seoul, South Korea
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
5364
引用
收藏
页码：I1236 / I1236
页数：1
相关论文
共 50 条
  • [1] CYTOMEGALOVIRUS INFECTION AFTER KIDNEY TRANSPLANTATION WITH PRE-EMPTIVE STRATEGY: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY
    Santisiripat, Chumpol
    Phonphok, Korntip
    TRANSPLANTATION, 2020, 104 (09) : S372 - S373
  • [2] Initial experience with oral valganciclovir for pre-emptive cytomegalovirus therapy after lung transplantation
    Aigner, C
    Jaksch, P
    Winkler, G
    Czebe, K
    Taghavi, S
    Marta, G
    Klepetko, W
    WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 (13-14) : 480 - 484
  • [3] Randomized Trial of Pre-Emptive or Prophylactic Valganciclovir Therapy for Prevention of Cytomegalovirus Infection in Renal Transplantation
    Delos Santos, Rowena
    Brennan, Daniel C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (09): : 1446 - 1448
  • [4] Oral valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic stem cell transplantation recipients
    Michael, M.
    Kourti, G.
    Bouzani, M.
    Grispou, O.
    Anagnostopoulou, M.
    Baltathakis, I.
    Apostolidis, I.
    Karakasis, D.
    Harhalakis, N.
    Paniara, O.
    Nikiforakis, E.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S285 - S286
  • [5] Prophylactic and pre-emptive therapy for cytomegalovirus infection in kidney transplant patients using oral valganciclovir
    Guirado, L.
    Rabella, N.
    Diaz, J. M.
    Facundo, C.
    Maderuelo, A.
    Margall, N.
    Silva, I.
    Garcia-Maset, R.
    Calabia, J.
    Gimenez, I.
    Garra, N.
    Sola, R.
    Ballarin, J. A.
    NEFROLOGIA, 2008, 28 (03): : 293 - 300
  • [6] Oral valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic stem cell transplantation recipients
    Pastore, D.
    Carluccio, P.
    Gaudio, F.
    Perrone, T.
    Delia, M.
    Albano, F.
    Manduzio, P.
    Fesce, V.
    Mongelli, P.
    Liso, V.
    Specchia, G.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S266 - S267
  • [7] Pre-Emptive Therapy for the Treatment of Cytomegalovirus After Kidney Transplantation
    Pretagostini, R.
    Poli, L.
    Lai, Q.
    Russo, G.
    Nudo, F.
    Garofalo, M.
    Melandro, F.
    Gaeta, A.
    Nazzari, C.
    Fazio, C.
    Di Simone, E.
    Vullo, V.
    Berloco, P. B.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (04) : 638 - 641
  • [8] Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation
    E Ayala
    J Greene
    R Sandin
    J Perkins
    T Field
    C Tate
    K K Fields
    S Goldstein
    Bone Marrow Transplantation, 2006, 37 : 851 - 856
  • [9] ORAL VALGANCICLOVIR IS EFFECTIVE AS PRE-EMPTIVE THERAPY FOR CYTOMEGALOVIRUS INFECTION IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS
    Atay, D.
    Erbey, F.
    Akcay, A.
    Dag, A.
    Ozturk, G.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S460 - S460
  • [10] Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation
    Ayala, E
    Greene, J
    Sandin, R
    Perkins, J
    Field, T
    Tate, C
    Fields, KK
    Goldstein, S
    BONE MARROW TRANSPLANTATION, 2006, 37 (09) : 851 - 856
12345